Tag: Boston
-
AC Immune/Genentech to Partner on R&D for Alzheimer’s Antibody; $418M Agree’t
AC Immune has entered into a second exclusive worldwide license agreement and research collaboration with Genentech,of the Roche Group, for the research, development and commercialization of AC Immune’s anti-Tau antibodies for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases. The agreement is valued at $400M.
-
Pasteur Institute Spin-out Ariana Pharma Opens Cambridge Office; Analytics Tech to Streamline Clinical Trials
Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.
-
Newsrooms Must Adopt “Innovation Culture” To Survive, Google Exec says
Cambridge writer Anita Harris reports on Google News Exec’s advice to newspaper industry at Nieman Foundation, May 11, 2012
-
Dance Review: Alvin Ailey in Boston: Stunning Integration of Past, Present, Future.
Anita Harris, New Cambridge Observer, reviews Alvin Ailey American Dance Theater performance of April 28, 2012.
-
Downturn + changing VC industry = funding challenges for startups
The economic recession of 2008 has led to soul-searching and innovation in the venture capital industry – to challenges for startups seeking funding, Boston VCs report .
-
Bio-IT World Review: BIG Data; BIG Promise; BIG CHALLENGES.
New Cambridge Observer’s Anita Harris on BIO-IT World 2012, describing the promise and problems presented by burgeoning of health care data.